Proteonomix, Inc. (PROT)

Market Cap	791.00 +9,787.5%
Revenue (ttm)	26.00K -27.8%
Net Income	-626.65K
EPS	-0.08
Shares Out	7.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,075
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-43.69
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Proteonomix

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: PROT

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 5, 2026

Data Sources Report a data error